<DOC>
	<DOC>NCT01893814</DOC>
	<brief_summary>To demonstrate benefit and tolerability of a probiotic product in infants with abdominal discomfort.</brief_summary>
	<brief_title>Benefit and Tolerability of a Probiotic Product in Infants With Abdominal Discomfort</brief_title>
	<detailed_description />
	<criteria>Male or female singleton ≥ 2 weeks and ≤ 12 weeks of age Exclusively breastfed at screening Abdominal discomfort (infant colic) in the week prior to enrollment, according to the statement of the parent(s) and/or guardian(s) Episodes of fussy crying that lasted at least 3 hours a day for at least 3 days in the 7 days prior to enrollment, according to the statement of the parent(s) and/or guardian(s) Voluntary, written informed consent of the parent(s) and/or guardian(s) to participate in the study Born at full term (3742 after last menstruation period) Birth weight: 2500 4500 g Weightforage ≥ 3th and ≤ 97th percentile according to WHO growth tables / charts Apparently healthy at birth (Apgar ≥ 8) and at screening visit No major complications during pregnancy or at birth Mother 1945 years of age at childbirth Ability of parent(s) and/or guardian(s) to attend visits, interviews and willingness to fill out questionnaires Intolerance to investigational product/its ingredients Severe medical condition or illness, congenital abnormality Gastrointestinal disorders (e.g. reflux esophagitis) Intake of probiotics and/or antibiotics in the week preceding recruitment and during the study Formula feeding at screening/randomisation Allergy or atopic disease (family history) Participation in another study Mother's health condition that may interfere with her ability to take care of her infant Mother affected by hepatitis B, HIV or GuillainBarré Syndrome Use of antibiotics by the mother in the week</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>12 Weeks</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>